We have earlier shown that CSF levels of NfH are higher in patients with evidence of axonal damage compared to those with purely demyelinating GBS, with CSF NfH levels predictive of outcome [9,39]. This evidence concerns the gene NEFH and Guillain-Barre syndrome.